Profound Medical CorpPROF
Price$5.85Intrinsic value$7.8334% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $18.8M+103.6% YoYTTM through 31 Mar 2026
Net Income -$38.9MTTM through 31 Mar 2026
Free Cash Flow -$38.5MTTM through 31 Mar 2026

Margins

Current
Gross Margin71.8%
Operating Margin-150.3%
Net Margin-132.2%

Returns

-65.5%ROE
-53.0%ROA

Balance Sheet Health

Debt / Equity0.08x
Current Ratio6.56x
Net Debt-$45.8Mnet cash position
Cash & Equivalents$50.3M

Quality Metrics

FCF Margin-204.7%
Earnings-Beat Rate75.0%

Dividend

No dividend
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.